Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury-Reference-Cited by-同舟云学术

Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury

Published:2007-11-22 Issue:6 Volume:88 Page:387-391
ISSN:0959-9673
Container-title:International Journal of Experimental Pathology
language:en
Short-container-title:

Author:

Togbe Dieudonnée,Schnyder-Candrian Silvia,Schnyder Bruno,Doz Emilie,Noulin Nicolas,Janot Laure,Secher Thomas,Gasse Pamela,Lima Carla,Coelho Fernando Rodrigues,Vasseur Virginie,Erard François,Ryffel Bernhard,Couillin Isabelle,Moser Rene

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2613.2007.00566.x/fullpdf

Reference37 articles.

1. Pathogen recognition and innate immunity;Akira;Cell,2006

2. Lipopolysaccharide-induced leukocyte-endothelial cell interactions: a role for CD14 versus toll-like receptor 4 within microvessels;Andonegui;J. Immunol.,2002

3. Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs;Andonegui;J. Clin. Invest.,2003

4. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans;Arbour;Nat. Genet.,2000

5. Genetic analysis of host resistance: toll-like receptor signaling and immunity at large;Beutler;Annu. Rev. Immunol.,2006

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-inflammatory and DNA Repair Effects of Astragaloside IV on PC12 Cells Damaged by Lipopolysaccharide;Current Medical Science;2024-08

2. Acute lung injury caused by sepsis: how does it happen?;Frontiers in Medicine;2023-11-21

3. Dietary iron modulates gut microbiota and induces SLPI secretion to promote colorectal tumorigenesis;Gut Microbes;2023-06-13

4. Liquiritin exhibits anti-acute lung injury activities through suppressing the JNK/Nur77/c-Jun pathway;Chinese Medicine;2023-04-03

5. The effects of lipoic acid on respiratory diseases;International Immunopharmacology;2023-03